Risk Reduce News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk reduce. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Reduce Today - Breaking & Trending Today

The biggest USP for many insurers


The biggest USP for many insurers
14-05-2021
More on this story
08-03-2021
Claims departments are now key to re/insurers’ offerings, and technology is a big part of that. Liberty Specialty Markets’ Irene Stavrou discusses the company’s investments and why claims are about much more than simply paying out.
As another Re/insurance Lounge panel titled “How the use of tech and service can set insurers apart” discussed, insurers’ claims departments have seen a transformation over the last two decades and there’s no sign of it slowing down. Investments in technology have made notification and payments smoother and simpler and led to a whole range of broader services. ....

City Of , United Kingdom , Irene Stavrou , Royal Society For The Prevention Of Accidents , Liberty Specialty Markets , Intelligent Insurer , Liberty Specialty , Risk Reduce , Royal Society , Virtual Rooms , Advanced Cat Response , Liberty Virtual Rooms , Irene Stavrou , நகரம் ஆஃப் , ஒன்றுபட்டது கிஂக்டம் , அரச சமூகம் க்கு தி ப்ரெவெந்ஶந் ஆஃப் விபத்துக்கள் , சுதந்திரம் சிறப்பு சந்தைகள் , சுதந்திரம் சிறப்பு , ஆபத்து குறைக்க , அரச சமூகம் , மெய்நிகர் அறைகள் ,

Blood plasma reduces risk of severe COVID-19 if given early


Katherine J Wu, The New York Times
Published: 07 Jan 2021 12:00 PM BdST
Updated: 07 Jan 2021 12:00 PM BdST
A patient recovered from COVID-19 donated plasma at the Hemotherapy Institute in La Plata, Argentina, in October. Agustin Marcarian/Reuters
A small but rigorous clinical trial in Argentina has found that blood plasma from recovered COVID-19 patients can keep older adults from getting seriously sick with the coronavirus if they get the therapy within days of the onset of the illness.
);
}
The results, published Wednesday in the New England Journal of Medicine, are some of the first to conclusively point toward the oft-discussed treatment’s beneficial effects. They arrive nearly five months after the Food and Drug Administration, under pressure from President Donald Trump, issued the therapy an emergency green light for use in people hospitalised with COVID-19. ....

New York , United States , Buenos Aires , Distrito Federal , Santa Fe , Donald Trump , Fernando Polack , Boghuma Kabisen Titanji , Taia Wang , Ilan Schwartz , University Of Alberta , York Times Company , National Institutes Of Health Do , Emory University , Albert Einstein College Of Medicine , Drug Administration , Montefiore Medical Center , Stanford University , New England Journal , President Donald Trump , National Institutes , Albert Einstein College , New York Times , Blood Plasma , Covid 19 , Risk Reduce ,